Denali Therapeutics Inc. DNLI Investment Income, Amortization of Discount
Investment Income, Amortization of Discount at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeAmortizationOfDiscount.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s investment income, amortization of discount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s investment income, amortization of discount?
- Denali Therapeutics Inc. (DNLI) reported investment income, amortization of discount of $1.26M in Q1 2026.
- How has Denali Therapeutics Inc.'s investment income, amortization of discount changed year-over-year?
- Denali Therapeutics Inc.'s investment income, amortization of discount decreased by 67.6% year-over-year, from $3.89M to $1.26M.
- What is the long-term trend for Denali Therapeutics Inc.'s investment income, amortization of discount?
- Over 2 years (2022 to 2025), Denali Therapeutics Inc.'s investment income, amortization of discount has grown at a 150.3% compound annual growth rate (CAGR), from $1.64M to $10.25M.
- What does investment income, amortization of discount mean?
- This represents the non-cash adjustment to net income related to the accretion of discounts or amortization of premiums on held-to-maturity or available-for-sale investment securities. It reflects the periodic recognition of interest income earned on the company's investment portfolio that has not yet been received in cash. Investors use this to reconcile reported net income with actual cash generated from investment activities.